This study is about testing if a team of doctors and scientists, called a Genomic Tumor Board (GTB), can help more patients get the right cancer treatment using their genetic test results. A genomic tumor test looks at the genes in cancer cells to help doctors choose the best treatment. Patients with certain types of cancer, like those that have come back, don't respond to usual treatment, or have spread, can join. The study compares the usual way of looking at test results to using the GTB for advice. The GTB meets weekly online to discuss patient cases and suggest treatments. Patients and their doctors are part of this study for up to 24 months.

• The study lasts for 24 months for patients and 6 months for doctors after their last patient joins.
• Doctors and patients will have online meetings to discuss treatment options.
• This study could help improve treatment decisions and doctors' understanding of genetic tests.

Patients must have a certain type of cancer and be at least 18 years old. Both doctors and patients need to agree to participate and sign a consent form.